Developing a Next Generation Sequencing Assay for the Clinic

Abstract

Acute Myeloid Leukemia (AML) is a malignancy of bone marrow stem/progenitor cells, and accounts for ~20,000 new cases per year in the United States. The 5 year survival rate is ~26%.  The mutation burden in many AML cases is... [ view full abstract ]

Authors

  1. Robert Fulton (Washington University in St. Louis)
  2. David Spencer (Washington University in St. Louis)
  3. Michelle O'Laughlin (Washington University in St. Louis)
  4. Susan Dutcher (Washington University in St. Louis)
  5. Tim Ley (Washington University in St. Louis)

Topic Area

Bringing sequence to the clinic (i.e., diagnostics, cancer, inherited disorders)

Session

OS-2 » Human Genomic Applications (13:00 - Tuesday, 16th May, La Fonda Ballroom)

Presentation Files

The presenter has not uploaded any presentation files.